Baseline tumor Lipiodol uptake after transarterial chemoembolization for hepatocellular carcinoma: identification of a threshold value predicting tumor recurrence
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-22. 10.1002/hep.2419921374666BruixJShermanMManagement of hepatocellular carcinoma: an updateHepatology20115310202210.1002/hep.24199Open DOISearch in Google Scholar
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-42. 10.1053/jhep.2003.5004712540794LlovetJMBruixJSystematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology2003374294210.1053/jhep.2003.50047Open DOISearch in Google Scholar
Idee JM, Guiu B. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review. Crit Rev Oncol Hematol 2013; 88: 530-49. 10.1016/j.critrevonc.2013.07.00323921081IdeeJMGuiuBUse of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a reviewCrit Rev Oncol Hematol2013885304910.1016/j.critrevonc.2013.07.003Open DOISearch in Google Scholar
Nakakuma K, Tashiro S, Hiraoka T, Uemura K, Konno T, Miyauchi Y, et al. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 1983; 52: 2193-200.10.1002/1097-0142(19831215)52:12<2193::AID-CNCR2820521203>3.0.CO;2-R6196102NakakumaKTashiroSHiraokaTUemuraKKonnoTMiyauchiYStudies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancerCancer1983522193200Open DOISearch in Google Scholar
Iwai K, Maeda H, Konno T. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res 1984; 44: 2115-21.6324996IwaiKMaedaHKonnoTUse of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray imageCancer Res198444211521Search in Google Scholar
Ohishi H, Uchida H, Yoshimura H, Ohue S, Ueda J, Katsuragi M, et al. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 1985; 154: 25-9. 10.1148/radiology.154.1.29811142981114OhishiHUchidaHYoshimuraHOhueSUedaJKatsuragiMHepatocellular carcinoma detected by iodized oil. Use of anticancer agentsRadiology198515425910.1148/radiology.154.1.2981114Open DOISearch in Google Scholar
Kan Z, Madoff DC. Liver anatomy: microcirculation of the liver. Semin Intervent Radiol 2008; 25: 77-85. 10.1055/s-2008-107668521326548KanZMadoffDCLiver anatomy: microcirculation of the liverSemin Intervent Radiol200825778510.1055/s-2008-1076685Open DOISearch in Google Scholar
Jinno K, Moriwaki S, Tanada M, Wada T, Mandai K, Okada Y. Clinicopathological study on combination therapy consisting of arterial infusion of Lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992; 31(Suppl): S7-12.10.1007/BF006870971333912JinnoKMoriwakiSTanadaMWadaTMandaiKOkadaYClinicopathological study on combination therapy consisting of arterial infusion of Lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinomaCancer Chemother Pharmacol199231(Suppl)S712Open DOISearch in Google Scholar
Choi BI, Kim HC, Han JK, Park JH, Kim YI, Kim, ST, et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 1992; 182: 709-13. 10.1148/radiology.182.3.13111161311116ChoiBIKimHCHanJKParkJHKimYIKimSTTherapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findingsRadiology19921827091310.1148/radiology.182.3.1311116Open DOISearch in Google Scholar
Takayasu K, Arii S, Matsuo N, Ryu M, Takasaki K, Sato M, et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol 2000; 175: 699-704. 10.2214/ajr.175.3.175069910954453TakayasuKAriiSMatsuoNRyuMTakasakiKSatoMComparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinomaAJR Am J Roentgenol200017569970410.2214/ajr.175.3.1750699Open DOISearch in Google Scholar
Kwan SW, Fidelman N, Ma E, Kerlan RK, Jr., Yao FY. Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl 2012; 18: 727-36. 10.1002/lt.2341322344899KwanSWFidelmanNMaEKerlanRKJrYaoFYImaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlationLiver Transpl2012187273610.1002/lt.23413Open DOISearch in Google Scholar
Imaeda T, Yamawaki Y, Seki M, Goto H, Iinuma G, Kanematsu M, et al. Lipiodol retention and massive necrosis after Lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol 1993; 16: 209-13.10.1007/BF026029628402781ImaedaTYamawakiYSekiMGotoHIinumaGKanematsuMLipiodol retention and massive necrosis after Lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathologyCardiovasc Intervent Radiol199316209138402781Open DOISearch in Google Scholar
Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 2001; 176: 681-8. 10.2214/ajr.176.3.176068111222205TakayasuKMuramatsuYMaedaTIwataRFurukawaHMuramatsuYTargeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival ratesAJR Am J Roentgenol2001176681810.2214/ajr.176.3.176068111222205Open DOISearch in Google Scholar
Rou WS, Lee BS, Moon HS, Lee ES, Kim SH, Lee HY. Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization. World J Gastroenterol 2014; 20: 6995-7004. 10.3748/wjg.v20.i22.699524944494RouWSLeeBSMoonHSLeeESKimSHLeeHYRisk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolizationWorld J Gastroenterol2014206995700410.3748/wjg.v20.i22.6995405194324944494Open DOISearch in Google Scholar
Kinugasa H, Nouso K, Takeuchi Y Yasunaka T, Onishi H, Nakamura S, et al. Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma. J Gastroenterol 2012; 47: 421-6. 10.1007/s00535-011-0492-922048256KinugasaHNousoKTakeuchiYYasunakaTOnishiHNakamuraSRisk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinomaJ Gastroenterol201247421610.1007/s00535-011-0492-922048256Open DOISearch in Google Scholar
European Association for the Study of The Liver, European Organisation for Rsearch and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-43. 10.1016/j.jhep.2011.12.00122424438European Association for the Study of The Liver, European Organisation for Rsearch and Treatment of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol2012569084310.1016/j.jhep.2011.12.00122424438Open DOISearch in Google Scholar
The Japan Society of Hepatology. Clinical Practice Guidelines for Hepatocellular Carcinoma 2013. [citated 2015 Sep 04]. http://www.jsh.or.jp/English/guidelines_en/Guidelines_for_hepatocellular_carcinoma_2013.The Japan Society of HepatologyClinical Practice Guidelines for Hepatocellular Carcinoma 2013[citated 2015 Sep 04]http://www.jsh.or.jp/English/guidelines_en/Guidelines_for_hepatocellular_carcinoma_2013Search in Google Scholar
Becker G. Creating comparability among reliability coefficients: the case of Cronbach alpha and Cohen kappa. Psychol Rep 2000; 87: 1171-82. 10.2466/pr0.2000.87.3f.117111272758BeckerGCreating comparability among reliability coefficients: the case of Cronbach alpha and Cohen kappaPsychol Rep20008711718210.2466/pr0.2000.87.3f.117111272758Open DOISearch in Google Scholar
Harvill LM. Standard error of measurement. Educational measurement: Issues and practice 1991; 10: 33-41. 10.1111/j.1745-3992.1991.tb00195.xHarvillLMStandard error of measurementEducational measurement: Issues and practice199110334110.1111/j.1745-3992.1991.tb00195.xOpen DOISearch in Google Scholar
Herber S, Biesterfeld S, Franz U, Schneider J, Thies J, Schuchmann M, et al. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol 2008; 31: 768-77. 10.1007/s00270-007-9270-818196335HerberSBiesterfeldSFranzUSchneiderJThiesJSchuchmannMCorrelation of multislice CT and histomorphology in HCC following TACE: predictors of outcomeCardiovasc Intervent Radiol2008317687710.1007/s00270-007-9270-818196335Open DOISearch in Google Scholar
Wang Z, Lin M, Lesage D, Chen R, Chapiro J, Gu T, et al. Three-dimensional evaluation of Lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT. Acad Radiol 2014; 21: 393-9. 10.1016/j.acra.2013.11.00624507426WangZLinMLesageDChenRChapiroJGuTThree-dimensional evaluation of Lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCTAcad Radiol201421393910.1016/j.acra.2013.11.006397992924507426Open DOISearch in Google Scholar
Shi M, Lu LG, Fang WQ, Guo RP, Chen MS, Li Y, et al. Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial. J Natl Cancer Inst 2013; 105: 59-68. 10.1093/jnci/djs46423150720ShiMLuLGFangWQGuoRPChenMSLiYRoles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trialJ Natl Cancer Inst2013105596810.1093/jnci/djs46423150720Open DOISearch in Google Scholar
Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, et al. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol 2010; 194: 830-7. 10.2214/AJR.09.330820173167TakayasuKAriiSIkaiIKudoMMatsuyamaYKojiroMOverall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysisAJR Am J Roentgenol2010194830710.2214/AJR.09.330820173167Open DOISearch in Google Scholar
